NCT07018427 2025-06-12
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Peking University Cancer Hospital & Institute
Active not recruiting
Peking University Cancer Hospital & Institute
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Zhejiang University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Seoul National University Bundang Hospital
Tongji Hospital